A random-control study of PMMA membrane as a filtrating agent of ascites in cell-free and concentrated ascites rein fusion therapy (CART) against patients with refractory ascites
- Conditions
- refractory ascites
- Registration Number
- JPRN-UMIN000031393
- Lead Sponsor
- Third Department of Internal Medicine, Nara Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Not provided
1) Patients with heart disease corresponding to the following a) Patients with NYHA class 3 or higher congestive heart failure b) Patients with poorly controlled hypertension 2) Patients with severe and active infections (excluding HBV and HCV) 3) Patients with history of HIV infection 4) Patients during hemodialysis 5) Patients with portal vein tumor plugs with Vp3 or more 6) Patients with hepatic encephalopathy who are difficult to properly hydrate 7) Patients who had gastrointestinal bleeding which clinically becomes problem within 4 weeks before the start of the study 8) Patients who received treatment corresponding to the following a) Systemic chemotherapy b) Invasive surgery within 4 weeks before the start of the study 9) Pregnant women Patients who have a possibility or intent during lactation and pregnancy 10) Patients who may have an allergic reaction to this test device 11) Health condition, psychological state, social situation that interferes with substance abuse, participation in this study and evaluation of results Patient involved 12) In addition, if there is a possibility of impairing patient safety in conducting this examination, or When it is judged that compliance is difficult
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method fever up within 24 hours after CART
- Secondary Outcome Measures
Name Time Method duration of next CART session